Although the cognitive dysfunction characterising AD is correlated with the accumulation of amyloid-β peptide (Aβ) deposits as well as tau-derived pathology [2], the molecular mechanisms underlying AD development are still not fully understood. Here, MAPT is linked to Alzheimer disease.